Conflict of interest
FOUNDER
HJL is founder of Neogene TC. KHJ has advisory roles at Astra-Zeneca, BIXINK, MSD, Novartis, Pfizer, Roche, Takeda and Everest Medicine. SBK is a consultant on the advisory boards of Novartis, AstraZeneca, Lilly, Dae Hwa Pharmaceutical Co. Ltd, ISU Abxis, and Daiichi-Sankyo, and has received research funding from Novartis, Sanofi-Aventis, and DongKook Pharm Co., and owns stock in Genopeaks and NeogeneTC. No other authors have any conflicts of interest to declare in relation to this study.